Morgan Stanley lowered the firm’s price target on Roche (RHHBY) to CHF 286 from CHF 312 and keeps an Equal Weight rating on the shares.Stay ...

The investment plans include new R&D sites in four US states and creating more than 12,000 jobs, according to the Swiss ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...